KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.05%.

  • TherapeuticsMD's Return on Capital Employed rose 1500.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.13% for FY2024, which is 100.0% up from last year.
  • As of Q3 2025, TherapeuticsMD's Return on Capital Employed stood at 0.05%, which was up 1500.0% from 0.06% recorded in Q2 2025.
  • TherapeuticsMD's 5-year Return on Capital Employed high stood at 4.47% for Q2 2022, and its period low was 1.12% during Q3 2021.
  • In the last 5 years, TherapeuticsMD's Return on Capital Employed had a median value of 0.06% in 2025 and averaged 0.44%.
  • Per our database at Business Quant, TherapeuticsMD's Return on Capital Employed soared by 53000bps in 2022 and then plummeted by -37800bps in 2023.
  • Over the past 5 years, TherapeuticsMD's Return on Capital Employed (Quarter) stood at 2.21% in 2021, then crashed by -99bps to 0.02% in 2022, then tumbled by -1268bps to 0.21% in 2023, then surged by 40bps to 0.13% in 2024, then soared by 60bps to 0.05% in 2025.
  • Its Return on Capital Employed stands at 0.05% for Q3 2025, versus 0.06% for Q2 2025 and 0.12% for Q1 2025.